Abstract:Introduction: The activation of the intrinsic AMP-activated protein kinase (AMPK) pathway plays an important role in the myocardial response to ischemia, pressure overload, and heart failure. The Notch1 signaling in the adult myocardium is activated transiently in response to myocardial injury, and it has implicated that Notch1 signaling may contribute to cardiac repair. However, the role of Notch1 signaling in myocardial infarction remain uncertain. Hypothesis: The cardioprotective AMPK signaling pathway could mediate the beneficial effects of Notch1 signaling cascade during myocardial infarction. Methods: C57BL/6J male mouse hearts were subjected in vivo to left anterior descending coronary artery ligation for 5 min, 20 min, 24 hr, 1 week and 2 weeks. Mice were treated with dibenzazepine (DBZ), a new Notch γ-secretase inhibitor (5 μmol/kg/day, i.p.) and the vehicle groups were treated with saline. Ischemic heart tissues were harvested for protein, mRNA expression and histologic analysis. Results: The Notch1 signaling was significantly activated during myocardial ischemia in vivo (p<0.05 vs. sham group). Interestingly, in the ex vivo heart perfusion system, systemic administration of DBZ to hearts led to significantly increase of myocardial infarct size and apoptosis caused by myocardial ischemia (p<0.05 vs. vehicle group). The immunoblotting results demonstrated that DBZ treatment significantly inhibited the AMPK activation by myocardial ischemia (p<0.05 vs. ischemia alone). Further immunoprecipitation experimental data showed that activated Notch1 strongly interacts with one AMPK upstream kinase, LKB1, to form a complex that modulates cardiac AMPK activation during myocardial ischemia. Moreover, the inhibition of Notch1 by DBZ impaired AMPK activation that significantly increased inflammation response such as activation of c-Jun N-terminal protein kinase (JNK) and NF-κB signaling during myocardial ischemia. Conclusions: The activated Notch1 signaling interacts with LKB1 to trigger the activation of cardioprotective AMPK signaling during myocardial ischemia. The Notch1-LKB1-AMPK signaling cascade could be a potential pharmacologic mimic for cardioprotection of ischemic heart disease.

c-Jun N-terminal Kinase (JNK-1) Confers Protection against Brief but Not Extended Ischemia during Acute Myocardial Infarction*

Delayed Inhibition Of C-Jun N-Terminal Kinase Worsens Outcomes After Focal Cerebral Ischemia

Neuroprotection Against Focal Ischemic Brain Injury by Inhibition of C-Jun N-terminal Kinase and Attenuation of the Mitochondrial Apoptosis-Signaling Pathway.

Gene inactivation of Na+/H+ exchanger isoform 1 attenuates apoptosis and mitochondrial damage following transient focal cerebral ischemia.

Increased Tolerance to Ischemic Neuronal Damage by Knockdown of Na+-Ca2+ Exchanger Isoform 1.

Critical role of c-jun N-terminal protein kinase in promoting mitochondrial dysfunction and acute liver injury

Neuroprotection Against Permanent Focal Cerebral Ischemia by Ginkgolides A and B is Associated with Obstruction of the Mitochondrial Apoptotic Pathway Via Inhibition of C‐jun N‐terminal Kinase in Rats

Isoform-specific functions of c-Jun N-terminal kinase 1 and 2 in lung ischemia-reperfusion injury through the c-Jun/activator protein-1 pathway

Effects of JNK signaling pathway on brain ischemia/reperfusion in rats

Activation of AMPK Inhibits Inflammatory Response During Hypoxia and Reoxygenation Through Modulating JNK-mediated NF-κB Pathway.

Mitochondrial JNK Activation Triggers Autophagy and Apoptosis and Aggravates Myocardial Injury Following Ischemia/reperfusion

Change of JNK MAPK and Its Influence on Cardiocyte Apoptosis in Ischemic Postconditioning

Abstract 12099: Activated Notch1 Interacting with LKB1 Reduces Myocardial Ischemic Injury Via Modulating AMPK Signaling Pathway

Cardioprotective Effects of a Selective c-Jun N-terminal Kinase Inhibitor in a Rat Model of Myocardial Infarction

Phosphorylation of JNK Increases in the Cortex of Rat Subjected to Diabetic Cerebral Ischemia.

Inhibition of the JAK2/STAT3 Pathway and Cell Cycle Re-Entry Contribute to the Protective Effect of Remote Ischemic Pre-Conditioning of Rat Hindlimbs on Cerebral Ischemia/reperfusion Injury.

Aberrant Activation of ASK1 Mediates Proinflammatory and Neurotoxic Microglial Responses After Cerebral Ischemia/Reperfusion

Blockade of the Translocation and Activation of Mitogen-Activated Protein Kinase Kinase 4 (MKK4) Signaling Attenuates Neuronal Damage During Later Ischemia-Reperfusion.

Phosphorylation and Protein Expression of C-Jun N-Terminal Protein Kinases in Cerebral Ischemia Preconditioning Rats

Cardioprotective Actions of Notch1 Against Myocardial Infarction Via LKB1-dependent AMPK Signaling Pathway

Role of JNK Signalling Pathway and Platelet‑lymphocyte Aggregates in Myocardial Ischemia‑reperfusion Injury and the Cardioprotective Effect of Ischemic Postconditioning in Rats.